{"name":"Taiwan Otsuka Pharm. Co., Ltd","slug":"taiwan-otsuka-pharm-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Meptin® Swinghaler","genericName":"Meptin® Swinghaler","slug":"meptin-swinghaler","indication":"Asthma","status":"phase_3"},{"name":"Ventolin® MDI","genericName":"Ventolin® MDI","slug":"ventolin-mdi","indication":"Acute asthma exacerbation and bronchospasm relief","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Berotec","genericName":"Berotec","slug":"berotec","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Meptin® Swinghaler","genericName":"Meptin® Swinghaler","slug":"meptin-swinghaler","phase":"phase_3","mechanism":"Meptin is a beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing in respiratory conditions.","indications":["Asthma","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Berotec","genericName":"Berotec","slug":"berotec","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ventolin® MDI","genericName":"Ventolin® MDI","slug":"ventolin-mdi","phase":"phase_3","mechanism":"Ventolin MDI delivers albuterol (salbutamol), a beta-2 adrenergic agonist that relaxes airway smooth muscle to rapidly relieve bronchospasm and improve airflow.","indications":["Acute asthma exacerbation and bronchospasm relief","Maintenance therapy for asthma and chronic obstructive pulmonary disease (COPD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPY3JVRTFOODNaWExGN1N2OGFMZHFVTGJSYXpkM28xU01Sb29qVFY2YVJnOFB1TGlGMVdKNkhtY3dyQV8yZHJmZ29MckFNcVZPWUxtSjRoNFB5WmlRM3IwZzZXZm94ZlBCTFBTeEJ4U2dpR3JDbnF1d3NmLXRyZjJuYTlRNkNvZFFUelpfT1J3X25lUmZxYVZrV0I4ZDNUMklYNUd4azlJWEpKNmhiV2VvOEN6c05PUjF5WkFFNWE3aWY0cXBuVFhOQm5Ka3NET0hzdC1ibmxZQUZFTEpOak9FTHhPeURQazVuTC11VnI5NFYzVUdULVg4WTFB?oc=5","date":"2026-02-13","type":"regulatory","source":"scanx.trade","summary":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment - scanx.trade","headline":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNNFc3TUJlR29YdDFwYjZJMnBXb3JGNHFMYUpHcmJXb2pGWXpNYjViVjFqUGY4SW9MTHBfei15T3RqME5tWURScWtpcnlvREhyUUhKSzN5b2ZfMUFkbV9yTjV5TS1mb242bVhGbEFkLUtzTGNrTmNZSDlNZ251b29xYU5GaGgyeVJsTXF6S2liS2tuX3JIMFprN1pTMkpYVHp4anJYR0xMNEZJSU90Mk9xZVpSUUVjV2VsY0RNQ3djcmVpN3BiTjVtc2RYcHBmRkZz?oc=5","date":"2025-09-26","type":"pipeline","source":"The Straits Times","summary":"Shares of Asian drugmakers drop after Trump imposes tariffs - The Straits Times","headline":"Shares of Asian drugmakers drop after Trump imposes tariffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBNa2N1aWd4WTNWZUNqeVJObWJTRWZfai1mV2ZxT2ktREZna3hLMUhQRFRHMHdVVER5SzhVM2pIQ3hSME96UHBreDJvNzBIc3hKcTE4eXdLVEpFMXpvaWlsajRoLWlBQnZTNS1qUGRCYlNGQQ?oc=5","date":"2025-09-22","type":"pipeline","source":"NutraIngredients.com","summary":"Japan focus: Suntory, Meiji, Otsuka Pharma and more - NutraIngredients.com","headline":"Japan focus: Suntory, Meiji, Otsuka Pharma and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQRE01YW1VN29pTDIwMjFIeUVHV2hycE13UUpjVngxbzgwZEVpaHZnS0RNYVo3Nl9qR19rS0I5dG1CMjlqTFFiYmpyM3JPUFoxMWZaWWVjOHM1SkRlN3huUEtMZEk3V0tjeW85SUtHc3JTeFVXX01IVWZUV1ZWY2p1c0lDSQ?oc=5","date":"2025-08-22","type":"trial","source":"Market Data Forecast","summary":"Psychiatry Therapies Market Size, Share & Growth, 2033 - Market Data Forecast","headline":"Psychiatry Therapies Market Size, Share & Growth, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPZTN0X3RHS0JuNzQ2Y24yd25EdTlvN2tETWtWdlYtd1NMekdCOFZrcTNtZlFhRTcwSF9GWnR2SUktTWE3VmZKcnhHSWZfaG5qZE9TbUdDczV2bmZaeG9LMmRvc3pZV3VMeHhUaHJLcDlwSkRBS0g3NjN4ZWg2THJha1NZcjJjVURHM28yWUdSQk9zWlNCZEEwQkM1aHdiSm5JWUJZbkRLRFhJUjE0amlQdnpfZVBNaE9ROVUteVdkRUw5VUFzY2xCb3ZtamhCcUhOdjkw?oc=5","date":"2025-08-20","type":"pipeline","source":"Plataforma Media","summary":"How 102 Taiwanese Companies are Reshaping Taiwan's Workplaces with Tech, Trust, and Inclusion - Plataforma Media","headline":"How 102 Taiwanese Companies are Reshaping Taiwan's Workplaces with Tech, Trust, and Inclusion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOYzhSdFhUci1CRUcyVVlhNFRZSG9LeHAwSHFlWHNUX2tTUDdfOURKUTFNNk5IUkR6SWE4V0U0bUNxNGJhX0tqMm1udHdiem9IWUtVNEtaNVdCQ0Z3T25ObU5hRW9XUGhPMlp5cURNWXJRR1V1WFV6R1NtekQ5WjhzVlFkaFdSREpvaXBVbzZDVGRDeVd4VzB4RkF2ckVNbFBXSE1tSGhaWVc1SXFrdFZPcVpBZVhIeDV5QTdvcEJRV2hIc1VXUS1vUWJsVDRDTzVIT1RiOXI0QnEyemYtVGJxQnBpWjVzVE9JVE9YWGpoUTZ4R1ZfdUxtWDBSNA?oc=5","date":"2025-06-22","type":"deal","source":"prnewswire.com","summary":"Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers - prnewswire.com","headline":"Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQYmtIbEtRV1J1bmFfRHdETjc5bW85SnlfZWQ0MU83aU41cXI5WWxLTXhpWmp1elhkMlBpMjFiM0ZSNkpxNEhFT25zY0FtLVprNEdWRGtBUGVjNzJ0Mk0wT0VoRGJaZ0p5ZkI2UVpyWmNtZ2FBX3JoejFtWmJuV29vU1paZWJCdE1GaFhNejdRVkc2cFpaVUE?oc=5","date":"2025-06-02","type":"pipeline","source":"Psychiatrist.com","summary":"What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon? - Psychiatrist.com","headline":"What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxORV9rNzJNLWJ2WWxXTktiM05GaUE3a3k2Z3dub2hlREZWUGdvVDBNT05Xbmh2U1lUWmFfMzFHaHhJY1Rhb2FmNWx6M3hwNW54YXQxeEZ3UFE1U1AyNy1JUVM4TTVLYVdEdGpkenJpaUZ1a2tyLUh6LWhMRGJjZVF5LUtVWmRPVTBVaXNKNXpTU2dNck5OaE1raVRYd1dwUXh4alRsemtURkZJc0VlUE1SdmpSYVpsZE16eXFuV3llaURzSVJ3MUtRYy1yYWFEaFJKZG42YndSbmhOV0U?oc=5","date":"2025-04-22","type":"pipeline","source":"prnewswire.com","summary":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight - prnewswire.com","headline":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOWEFtd2tKY01LelM4Y1VZY0xmV2xGNE5Zd2JDcmVDUE4wa2NxeWxuMk14ZWhqbUg0Z2s2dlFnZVN5bG9SMllyai1FdGlPbjRkc2ZXQ0FZS2s5eTFVTUp2NEp1blJjY1FhYk90eDRvdG9OcHBvVEo2dGpHVXBEV2pFVFFfNTVfXzY3U3pJdk1ZVEhSTUE?oc=5","date":"2024-08-01","type":"deal","source":"Contract Pharma","summary":"Otsuka Agrees to Acquire Jnana Therapeutics - Contract Pharma","headline":"Otsuka Agrees to Acquire Jnana Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5jcHRid01JZnR5YU1SLWFWd0ZKSm5ETVhBc2d6LXlXV1hJZlJUc1U4ZWdSSXkxVVFvRUhDYzFxci1VeWVBbzhPem52bEdnRGEyOFU3Z3ZxV2lJRjB3NUZuUzZKcE85aDRTM2JkMm9TRUFkdHB4c3ZRMQ?oc=5","date":"2024-06-10","type":"pipeline","source":"otsuka.co.jp","summary":"Korea Otsuka Pharmaceutical Launches Soy Bar \"SOYJOY\" Introducing a New Concept of Healthy Snacking - otsuka.co.jp","headline":"Korea Otsuka Pharmaceutical Launches Soy Bar \"SOYJOY\" Introducing a New Concept of Healthy Snacking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5GaG50VUpkRzZSazF0V1QtMGd3X0h4M190RUhUNkVVamhHbk1mMG9sLW9IZk0wVkg3cUlVUjRtUUpFbTZpQ2EtOWtxcEE5eVZpSHNxV3A2MFFtZTR3V0J2MmF1bWpCd3BvajRjMTd3?oc=5","date":"2024-05-08","type":"regulatory","source":"Straits Research","summary":"Gastroparesis Drugs Market Size, Share, Trends & Demand 2033 - Straits Research","headline":"Gastroparesis Drugs Market Size, Share, Trends & Demand 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOUFJTF9pQjZkZHlEZm9lLS1NcnQ2eGRqbUhPMXVsalpHUHlLWGxFQWc0SEpDZ1hNQTVKODVKV2pEc3hwQ1FUS051NFhvbWF2LWQ2Ny1oTzh2clJLcFgzdGdhcF9LWDltLURfWWxpRE4wTm0xQ0UyWGNZcjVtT21vclY4R3Y2X3RvSXBsSVhxM29BTjQ3YllGMlpwN0V4a3J2ZlE0Mk5Da2U?oc=5","date":"2024-01-30","type":"deal","source":"BioWorld News","summary":"Travere licenses out rare kidney disease drug to Renalys in Asia - BioWorld News","headline":"Travere licenses out rare kidney disease drug to Renalys in Asia","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}